BioCatalyst

ZBIO — Zenas BioPharma, Inc. catalysts

1 verified catalyst event(s) for Zenas BioPharma, Inc. (ticker ZBIO). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-06-30 — A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-30
in 8d
ESTIMATED
 READOUT
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAr
Phase 3 · Warm Autoimmune Hemolytic Anemia
 ZBIO Zenas BioPharma, Inc. Obexelimab, Obexelimab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.